Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2015

Jan 7, 2015

32414_dirs_2015-01-06_c058cd0f-d445-4082-9257-5bc4d6cbdf17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-01-02

Reporting Person: Gold Mark Stephen (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-01-02 Stock Option (right to purchase) $0.00 A 15000 Acquired 2022-01-02 Common Stock (15000) Direct

Footnotes

F1: Annual option grant as compensation for services on the board of directors. Options vest as to 25% of total share amount at the end of each fiscal quarter, becoming fully vested after one year.